Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 11, 2022
Source ID
10.1038/s41388-022-02276-z

Entities

People

  • Armen G. Aprikian
  • Eleonora Scarlata
  • Erwan Pernet
  • Fadi Brimo
  • Jacques Lapointe
  • Karl-philippe Guérard
  • Lucie Hamel
  • Maziar Divangahi
  • Ola Kassem
  • Shaghayegh Rouzbeh
  • Simone Chevalier
  • Vincent Giguère
  • Yogesh M. Bramhecha
  • Étienne Audet-Walsh

Organizations

  • Canadian Institutes of Health Research
  • Fonds de Recherche du Québec Santé
  • McGill University Faculty of Medicine and Health Sciences
  • Prostate Cancer Canada
  • United States Department of Defense